Quit Genius Medical

NEW YORK, Dec. 12, 2022 (GLOBE NEWSWIRE) -- Quit Genius, the world’s first digital clinic for treating multiple substance addictions, today announced results from a pilot study of integrated alcohol use disorder (AUD) treatment. The…

NEW YORK, Sept. 15, 2022 (GLOBE NEWSWIRE) -- Two additional solutions by Quit Genius, the world’s first digital clinic for treating multiple substance addictions, have been added to the Evernorth Digital Health Formulary, which connects…

NEW YORK, May 05, 2022 (GLOBE NEWSWIRE) -- Quit Genius, the world’s first digital clinic for treating multiple substance addictions, announced today that a new study published in Nicotine & Tobacco Research found that the Quit Genius…

NEW YORK, Nov. 30, 2021 (GLOBE NEWSWIRE) -- Quit Genius, the world’s first digital clinic for treating multiple addictions, announced today that two new peer-reviewed studies have found that the Quit Genius tobacco cessation program…

NEW YORK, Nov. 17, 2021 (GLOBE NEWSWIRE) -- Quit Genius, the world’s first digital clinic for treating multiple substance addictions, announced today that it has earned The Joint Commission’s Gold Seal of Approval® Accreditation by…